CAPOBIANCO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 1.031
EU - Europa 702
AS - Asia 375
OC - Oceania 28
SA - Sud America 28
AF - Africa 11
Totale 2.175
Nazione #
US - Stati Uniti d'America 998
IT - Italia 235
CN - Cina 134
IE - Irlanda 78
SG - Singapore 77
FR - Francia 69
DE - Germania 56
SE - Svezia 47
VN - Vietnam 32
GB - Regno Unito 30
NL - Olanda 27
BE - Belgio 24
AU - Australia 23
IN - India 19
PL - Polonia 19
CA - Canada 17
UA - Ucraina 17
ES - Italia 16
FI - Finlandia 16
HK - Hong Kong 15
ID - Indonesia 15
MX - Messico 15
IR - Iran 14
NO - Norvegia 14
BR - Brasile 13
JP - Giappone 12
RU - Federazione Russa 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
TR - Turchia 9
LB - Libano 8
CH - Svizzera 7
EC - Ecuador 7
KR - Corea 7
AT - Austria 6
EG - Egitto 6
PT - Portogallo 6
TW - Taiwan 6
NZ - Nuova Zelanda 5
AR - Argentina 3
CO - Colombia 3
DK - Danimarca 3
GR - Grecia 3
HR - Croazia 3
IL - Israele 3
PH - Filippine 3
RO - Romania 3
SA - Arabia Saudita 3
TH - Thailandia 3
UZ - Uzbekistan 3
JO - Giordania 2
LT - Lituania 2
MA - Marocco 2
TG - Togo 2
CI - Costa d'Avorio 1
CL - Cile 1
KY - Cayman, isole 1
PK - Pakistan 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 2.175
Città #
Chandler 169
Fairfield 78
Dublin 75
Beijing 66
Singapore 63
Ashburn 56
Ann Arbor 47
Seattle 41
Woodbridge 27
Houston 26
Wilmington 26
Cambridge 25
Nyköping 25
Medford 24
Milan 24
Dong Ket 23
Santa Clara 22
Genoa 19
Columbus 18
Princeton 18
Turin 17
Brussels 16
Pisa 16
Torino 16
Jacksonville 15
Jakarta 15
Paris 15
Hangzhou 14
Dearborn 13
Munich 13
Villeurbanne 13
Redwood City 11
Guangzhou 10
Rome 10
Warsaw 10
Helsinki 9
Marília 8
San Diego 8
St-Malo 8
Amsterdam 7
Barcelona 7
Melbourne 7
Pune 7
Québec 7
Tokyo 7
Beirut 6
Boisgervilly 6
Nanjing 6
Taipei 6
Bologna 5
Cuenca 5
Duncan 5
Foggia 5
Hamburg 5
Hong Kong 5
Kirov 5
Liège 5
Mexico City 5
New York 5
Prague 5
Udine 5
Vienna 5
Alexandria 4
Auckland 4
Braga 4
Cairo 4
Canandaigua 4
Central 4
Denver 4
Eskişehir 4
Eygelshoven 4
Fremont 4
Heiligenhaus 4
Norwalk 4
Padova 4
Seoul 4
Adelaide 3
Berlin 3
Bradenton 3
Bradford 3
Canberra 3
Dubai 3
Edinburgh 3
Edmonton 3
Florence 3
Fuzhou 3
Geneva 3
Huddinge 3
Istanbul 3
Johnson City 3
Lanzhou 3
Lexington 3
Lillehammer 3
London 3
Marseille 3
Medellín 3
Mulhouse 3
Naples 3
Novara 3
Rzeszów 3
Totale 1.368
Nome #
Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis 609
The Case | the young philosopher with multiple sclerosis and proteinuria 200
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 171
Anal sphincter dysfunction in multiple sclerosis: An observation manometric study 167
Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders 159
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients 105
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 77
Mitoxantrone-related acute myeloid leukaemia, induced one year after the discontinuation of mitoxantrone therapy 71
The still under-investigated role of cognitive deficits in PML diagnosis 66
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers 64
Switching to alemtuzumab from fingolimod or other therapies: impact of wash-out period on disease activity 63
Acute renal failure, severe sodium and potassium imbalance and sudden tetraplegia 62
A real-world study of Alemtuzumab in a cohort of Italian patients 60
Early diagnosis of progressive multifocal leucoencephalopathy: Longitudinal lesion evolution 60
NURR1-deficient mice have age- and sex-specific behavioral phenotypes 53
A Real-Life Study of Alemtuzumab: Impact of Previous Therapies and Washout Period on Disease Activity 51
Shift from fingolimod to alemtuzumab: what happens next? 51
To do or not to do? plasma exchange and timing of steroid administration in progressive multifocal leukoencephalopathy 43
MS Italian patients manifesting natalizumab-related PML between 2009 and 2014. Report of the Italian group for MS-PML study 42
Fetal and post-natal growth in infants of mothers with multiple sclerosis: A case-control stud 23
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 15
Sars-CoV2 infection in pregnant women with multiple sclerosis 14
Expression and regulation of IFNα/β receptor in IFNβ-treated patients with multiple sclerosis 5
Totale 2.231
Categoria #
all - tutte 6.994
article - articoli 0
book - libri 0
conference - conferenze 1.667
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020119 0 0 0 0 6 15 21 18 23 18 5 13
2020/2021242 11 10 14 41 27 6 5 23 19 23 12 51
2021/2022342 15 15 17 22 20 34 32 14 20 27 66 60
2022/2023681 56 61 48 66 71 94 58 38 46 42 73 28
2023/2024383 38 53 24 20 45 51 22 20 7 22 24 57
2024/2025233 28 11 42 69 83 0 0 0 0 0 0 0
Totale 2.231